Your browser doesn't support javascript.
loading
Validation of the Italian version of the pediatric CMT quality of life outcome measure.
Moroni, Isabella; Danti, Federica Rachele; Pareyson, Davide; Pagliano, Emanuela; Piscosquito, Giuseppe; Foscan, Maria; Marchi, Alessia; Ardissone, Anna; Genitrini, Silvia; Wu, Tong Tong; Shy, Michael E; Ramchandren, Sindhu.
Afiliação
  • Moroni I; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Danti FR; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Pareyson D; Rare Neurodegenerative and Neurometabolic Diseases Unit, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Pagliano E; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Piscosquito G; Department of Neurology, Azienda Ospedaliera Universitaria "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
  • Foscan M; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Marchi A; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Ardissone A; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Genitrini S; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Wu TT; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.
  • Shy ME; Department of Neurology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Ramchandren S; Janssen Pharmaceutical Companies of Johnson and Johnson, Titusville, New Jersey, USA.
J Peripher Nerv Syst ; 27(2): 127-130, 2022 06.
Article em En | MEDLINE | ID: mdl-35416371
ABSTRACT
The pediatric Charcot-Marie-Tooth (CMT) specific quality of life (QOL) outcome measure (pCMT-QOL) is a recently developed and validated patient-reported measure of health QOL for children with CMT. The aim of this study was to provide and validate an Italian version of the pCMT-QOL. The original English version was translated and adapted into Italian using standard procedures. pCMT-QOL was administered to patients genetically diagnosed with CMT, aged 8 to 18 years. A retest was given 2 weeks later to assess reliability in all patients. A total of 22 patients (median age 14 years, DS 2.5; MF 11) affected with CMT (19 CMT1A, 2 CMT2A, 1 CMT2K) were assessed as part of their clinical visit. The Italian-pCMT-QOL demonstrate a high test-retest reliability. None of the patients experienced difficulty in completing the questionnaire, no further corrections were needed after administration in patients. The Italian-pCMT-QOL is a reliable, culturally adapted and comparable version of the original English pCMT-QOL. This questionnaire is expected to be valuable in monitoring disease progression and useful for future clinical trials in Italian-speaking children with CMT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doença de Charcot-Marie-Tooth Tipo de estudo: Diagnostic_studies Limite: Adolescent / Child / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doença de Charcot-Marie-Tooth Tipo de estudo: Diagnostic_studies Limite: Adolescent / Child / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article